We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Try the New Site
We're building a modernized ClinicalTrials.gov! Visit Beta.ClinicalTrials.gov to try the new functionality.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03177239
Brief Title: Phase II Sequential Treatment Trial of Single Agent Nivolumab, Then Combination Ipilimumab + Nivolumab in Metastatic or Unresectable Non-Clear Cell Renal Cell Carcinoma (ANZUP1602) (UNISoN)
First Submitted : June 4, 2017
First Submitted that Met QC Criteria : June 4, 2017
First Posted : June 6, 2017
Last Update Submitted that Met QC Criteria : February 14, 2022
Last Update Posted : February 16, 2022